These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12740553)

  • 21. The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials.
    Ferdinand KC
    Clin Cardiol; 2004 Jun; 27(6 Suppl 3):III12-5. PubMed ID: 15239486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and future treatment of hyperlipidemia: the role of statins.
    Farnier M; Davignon J
    Am J Cardiol; 1998 Aug; 82(4B):3J-10J. PubMed ID: 9737640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M; Lavallée PC; Labreuche J; Amarenco P
    Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns and effectiveness of lipid-lowering therapies in a managed care environment.
    Meyer JW; Schultz JS; O'Donnell JC; Patel PA; Sasane RM
    Value Health; 2005; 8(5):601-12. PubMed ID: 16176498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions in the management of serum lipids for preventing stroke recurrence.
    Manktelow BN; Potter JF
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD002091. PubMed ID: 19588332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke prevention and statin treatment.
    Parnetti L; Caso V; Lanari A; Saggese E; Sebastianelli M; Tayebati SK; Amenta F
    Clin Exp Hypertens; 2006; 28(3-4):335-44. PubMed ID: 16833043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM;
    Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol lowering in the older population: time for reassessment?
    Kagansky N; Levy S; Berner Y; Rimon E; Knobler H
    QJM; 2001 Sep; 94(9):457-63. PubMed ID: 11528008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
    Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
    Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
    Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins in the 21st century: end of the simple story?
    Doggrell SA
    Expert Opin Investig Drugs; 2001 Sep; 10(9):1755-66. PubMed ID: 11772284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins and LDL-cholesterol lowering: an overview.
    Stroes E
    Curr Med Res Opin; 2005; 21 Suppl 6():S9-16. PubMed ID: 16138936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of lipid-modifying therapy in the prevention of initial and recurrent stroke.
    Hankey GJ
    Curr Opin Lipidol; 2002 Dec; 13(6):645-51. PubMed ID: 12441889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of statins in stroke prevention.
    Amarenco P
    Curr Opin Lipidol; 2005 Dec; 16(6):614-8. PubMed ID: 16276237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Niacin as a component of combination therapy for dyslipidemia.
    Miller M
    Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Statins in stroke prevention].
    Gedikli O; Baykan M
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of hyperlipidaemia.
    Stocks N; Allan J; Mansfield PR
    Aust Fam Physician; 2005 Jun; 34(6):447-53. PubMed ID: 15931403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bempedoic acid as adjunct for traditional lipid-lowering therapy in patients with hyperlipidaemia.
    Schimmenti C; Sucato V; Manzone E; Cancellieri G; Mortillaro F; Novo G; Galassi AR; Venturella F
    Coron Artery Dis; 2021 Jun; 32(4):340-344. PubMed ID: 33229935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.